Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy
Rosa Bacchetta(Lucile Packard Children's Hospital), Maria‐Grazia Roncarolo(Vita-Salute San Raffaele University), Maurilio Ponzoni(San Raffaele University of Rome), Katharina Fleischhauer(German Cancer Research Center), Silvia Gregori(The San Raffaele Telethon Institute for Gene Therapy), Carlo Paties(Vita-Salute San Raffaele University), Ulrike Schulz(University of Regensburg), Gianluca Serafini(Ospedale Policlinico San Martino), Claudia Sartirana(The San Raffaele Telethon Institute for Gene Therapy), Stefan Tomiuk(European Union), E. Zino(The San Raffaele Telethon Institute for Gene Therapy), U. Jansen(Miltenyi Biotec (Germany))
Cited by 63
Related Papers
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
|The Journal of Experimental Medicine|1996|774
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752
Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review
|Journal of Affective Disorders|2020|704